JG
SCLN

Jefferies Group’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Jefferies Group’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-7,420
Closed -$73K – 3531
2015
Q2 		$73K Buy
+7,420
New +$67.6K ﹤0.01% 2311

Other funds holding SCLN

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SI
Sensato Investors San Francisco, California $122M AUM 5.69% 1-Year Est. Return

Jefferies Group's SCLN Position: Q3 2015 in Review

Jefferies Group sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q3 2015, closing a stake of 7,420 shares — an estimated $73K sold.

Jefferies Group first reported a position in SCLN in Q2 2015 and held it in 1 quarter. The position peaked at $73K in Q2 2015. 134 funds tracked by Wall St. Rank hold SCLN as of Q3 2015.

  • Jefferies Group reported no remaining Sciclone Pharmaceuticals Inc position as of Q3 2015 after selling out during the quarter.
  • Jefferies Group sold 7,420 Sciclone Pharmaceuticals Inc shares in Q3 2015, an estimated $73K.
  • Jefferies Group first reported a position in Sciclone Pharmaceuticals Inc in Q2 2015 and held it in 1 quarter.
  • Jefferies Group's Sciclone Pharmaceuticals Inc position peaked at $73K in Q2 2015.
  • 134 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q3 2015.

Based on Jefferies Group's 13F filing for Q3 2015, filed 13 Nov 2015.